Inhibitors of histone deacetylase (HDAC) block cell cycle progression at Gl in many cell types. Weinvestigated the mechanism by which trichostatin A (TSA), a specific inhibitor of HDAC, induces Gl arrest in human cervix carcinoma HeLa cells. TSAtreatment induced histone hyperacetylation followed by growth arrest in Gl as well as hypophosphorylation of pRb. The Cdk4 kinase activity was essentially unchanged during the TSA-induced Gl arrest. On the other hand, the arrest was accompanied by down-regulation of kinase activity of Cdk2, although the total protein levels of Cdk2 and its activator Cdc25A were unaffected. Upon TSA treatment, amounts of cyclin E and the CDKinhibitor p2lWAF1/QP1were markedly increased, while that of cyclin A was reduced. The induction of p21 and down-regulation of cyclin A correlated well with the decreased Cdk2 activity and cell cycle arrest. Furthermore, gel filtration chromatography showed the association of p21 with the cyclin E-Cdk2 complex, suggesting that the activation of Cdk2 by the enhanced expression of cyclin E is blocked by the increased p21. The elevated expression of p21 is also observed in cells treated with trapoxin and FR901228, structurally unrelated histone deacetylase inhibitors.
Inhibitors of histone deacetylase (HDAC) block cell cycle progression at Gl in many cell types. Weinvestigated the mechanism by which trichostatin A (TSA), a specific inhibitor of HDAC, induces Gl arrest in human cervix carcinoma HeLa cells. TSAtreatment induced histone hyperacetylation followed by growth arrest in Gl as well as hypophosphorylation of pRb. The Cdk4 kinase activity was essentially unchanged during the TSA-induced Gl arrest. On the other hand, the arrest was accompanied by down-regulation of kinase activity of Cdk2, although the total protein levels of Cdk2 and its activator Cdc25A were unaffected. Upon TSA treatment, amounts of cyclin E and the CDKinhibitor p2lWAF1/QP1were markedly increased, while that of cyclin A was reduced. The induction of p21 and down-regulation of cyclin A correlated well with the decreased Cdk2 activity and cell cycle arrest. Furthermore, gel filtration chromatography showed the association of p21 with the cyclin E-Cdk2 complex, suggesting that the activation of Cdk2 by the enhanced expression of cyclin E is blocked by the increased p21. The elevated expression of p21 is also observed in cells treated with trapoxin and FR901228, structurally unrelated histone deacetylase inhibitors.
A human colorectal carcinoma cell line lacking both alleles ofthep21 gene (p21 -/-) was resistant to TSAseveral times more than the parental line (p21 +/+). These results suggest that the suppression of Cdk2 kinase activity due to p21 overexpression play a critical role in HDACinhibitor-induced growth inhibition.
A large number of natural products and synthetic compounds were extensively screened for inhibitors of eukaryotic cell cycle. We previously reported that trichostatin A (TSA)1' 2*, trapoxin3), and FR9012284) ( Fig.  1 ), which had been described to cause cell cycle arrest in various cultured cell lines, were inhibitors of histone deacetylase (HDAC). All of these inhibitors cause arrest of the cell cycle in Gl and/or G2, suggesting that histone acetylation is involved in cell cycle control4'5^. Acetylation and deacetylation are catalyzed by specific enzymes, histone acetyltransferase (HAT) and deacetylase, respectively. The net level of acetylation is determined by an equilibrium between these two enzymes6). Inhibition of HDAC therefore causes hyperacetylation of chromatin. Recently, a number of transcriptional repressors were shown to recruit the HDAC complex to the promoter regions. For example, hypophosphorylated pRb recruits HDACto repress the E2F-dependent transcription7 '8) .
TSA and trapoxin can abrogate transcriptional repression caused by these repressor-corepressor complexes. These findings suggest that histone acetylation plays an important role in the regulation of the cell cycle through an alteration of gene expression. Since some of the HDAC inhibitors show strong antitumor activity4?9), a better understanding of the precise mechanism by which HDACinhibitors cause cell cycle arrest may provide new insights into cancer chemotherapy.
In the present study, we investigated the effects of TSA on the cell cycle progression in HeLa, and showed that TSA caused up-regulation of p21 and inhibition of Cdk2 activity This paper is dedicated to Late Sir Edward P. Abraham in memoryof his great contribution to the field of antibiotics. leading to hypophosphorylation of pRb. Experiments with a p21-null cell line suggest an important but insufficient role ofp2 1 in HDAC-induced growth inhibition.
Materials and Methods

Culture Conditions and Analysis of Cell Proliferation
The cell lines used in this study were maintained in Dulbecco's modified Eagle's medium (DMEM) (Nissui Pharmaceutical Co. Ltd.) supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, UT). Effects of TSAon cell proliferation were determined using a MTT assay10) and BrdU incorporation.
Cell Labeling and Immunoprecipitation HeLacells that had been grown in 100-mmtissue culture dishes were treated with or without 500ng/ml of TSAfor 18hours in DMEM complemented with 10% FCS. After cells had been washedtwice with methionine-and cysteinefree DMEM(Sigma Chemical Co., St. Louis, MO), the cells were preincubated in the starved mediumfor 20 minutes. Science, Buckinghamshire, UK) per 100-mm dish in the presence or absence 500ng/ml of TSA. The cells were washed with cold PBS and lyzed in IP buffer (50mM HEPES, 150niM NaCl, 1mM EDTA, 2.5mM EGTA, 0.1% Tween 20, 10% glycerol, 0.1 mMphenylmethylsulfonyl fluoride, 10mM /}-glycerophosphate, 1 mMNaF, 0.1 mM Na3VO4, lO^g/ml aprotinin and 10mMleupeptin, pH 7.5).
Labeled pRb was immunoprecipitated with an anti-pRb antibody, the immunecomplexes were detected with an ECL Western blotting kit (Amersham Pharmacia Biotech.).
Gel Filtration Chromatography
Cell lysates (2-5mg protein) prepared by freezethawing in IP buffer were fractionated on a Superose 12 gel filtration column using a fast protein liquid chromatography system (Pharmacia Biotech, Uppsala, Sweden). The fractions (0.5 ml) eluted with 50mM Tris-HCl (pH 7.4), 200 mMKC1as the eluent were collected and the proteins were concentrated by acetone precipitation prior to SDS-PAGE (Fig. 3A) whether Cdk2 and Cdk4 activity was influenced by the TSA treatment by using in vitro kinase assays. As shown in Fig  3B, the histone HI kinase activity in the immunoprecipitate containing Cdk2 was not significantly affected until 6hours after TSAaddition, but was reduced at 12hours. At 24 hours, the activity was less than one fifth of the initial level. The inhibition was continued for at least 6 hours even after the drug removal, but it was completely abolished 12 hours after removal of TSA. The time course of the Cdk2 activity correlated well with the cell cycle arrest and restart. On the other hand, the Rb kinase activity of Cdk4 was unaffected by TSA (Fig. 3B) . The suppression of Cdk2 activity was not due to the reduced expression, since the Cdk2 protein level was constant, irrespective of the presence and absence of TSA, as determined by Western blotting of the Cdk2 immunoprecipitates used for the kinase assay (Fig. 3C ). Cdk2 is also post-translationally regulated by phosphorylation and dephosphorylation.
However, no obvious band shift implying changes in the phosphorylation level of Cdk2 was observed (Fig. 3C) concentrations were examined by Western blotting, the expression of cyclin A, a component of Cdk2 complex required for Gl/S transition, was markedly suppressed by TSAat the concentrations higher than 200 ijg/ml (Fig. 4A) where the cell cycle progression is inhibited ( Fig. 2A) , whereas cyclin E, another partner of Cdk2, was upregulated in a dose-dependent manner. Time course experiments showedthat the amount of cyclin A decreased 12hours after TSA addition but increased again 12hours after TSAremoval (Fig. 4B) . The dose-and time-dependent changes in the amount of cyclin A correlated with those of BrdU incorporation and Cdk2 activity. In contrast, the amount of cyclin E began to increase within 6hours after TSAaddition and the level was retained even 18 hours after drug removal. The amount of cyclin E induced by TSA was much larger than that in control exponentially growing cells, suggesting that it is sufficiently high for Cdk2 to be active. These results suggest that the decrease in the amount of cyclin A alone cannot fully account for downregulation of Cdk2 activity.
TSA Up-regulates p21 Expression
To test whether the changes in the amountof CKIsare responsible for the decreased Cdk2 activity, we examined the effect of TSA on expression of p21 and p27, both of which inhibit the Cdk2 kinase complex. The amount ofp21 was markedly elevated in the cells treated with more than 200ng/ml TSA, whereas that of p27 was not significantly altered (Fig. 4A ). Similar analysis with extracts from the cells collected at various times during TSA treatment showed a dramatic increase in the amount of p21 when treated with 500 ng/ml of TSA for 12hours or longer (Fig.  4B) , at which time Cdk2 activity was markedly reduced (B) Time-course. HeLa cells were added with 500 ng/ml of TSAat time 0, cultured for the indicated times (+), then released from the block 24hours after the TSA challenge (+/-), and further cultured for additional 24hours without TSA (-). Changes in the amounts of the endogenous cell cycle proteins were analyzed by Western blotting. (Fig. 3B) . The level of p21 decreased 12 hours after the drug removal. These patterns of change in p21 in response to TSAcorrelate oppositely with those in Cdk2 activity and cell cycle progression. This observation raised a possibility that the increase in the amount ofp21 is responsible for the decrease in the Cdk2 kinase activity.
Association ofp21 with Cdk2
Each component in the CDKcomplexes with different compositions and activities can be resolved by gel filtration chromatography. To investigate whether the elevated p2 1 is actually associated with the cyclin-Cdk2 complex, we analyzed the components in the complexes including Cdk2 by using a Superose 12 HR gel filtration column, which separates native proteins at high resolution. Figure 5 shows a typical pattern obtained from three independent experiments; each fraction obtained by chromatography was analyzed by immunoblotting for p21, p27, Cdk2, cyclin E and cyclin A. Cdk2 eluted in two major peaks. One peak eluted at an apparent molecular massof~40kDa,close to the expected position of monomeric Cdk2 (Fig. 5) . The other peak, representing the majority of the Cdk2, eluted as a broad peak with an apparent molecular mass of 1000 kDa~100kDa. These results are consistent with previous observations by others14). Cyclin E coeluted with the peak containing the larger Cdk2 complex (Fig. 6) . Cyclin A was not detected by immunoblotting over the entire fractions (data not shown), consistent with the above-described observation that the amount of cyclin A decreased in TSA- treated cells (Fig. 4) . The fractions containing p21, which eluted as a single major broad peak, encompassed the larger Cdk2 complex probably associated with cyclin E. p21
neither eluted in the fractions of expected position of its monomericform nor coeluted with the other peak of Cdk2.
Association of p21 with Cdk2 was also verified by immunoprecipitation (data not shown). These data demonstrate that most Cdk2 proteins form a complex with not only cyclin E, but also with p21 in TSA-treated cells. The tight association of the increased p21 with the cyclin E-Cdk2 complex explains why the cyclin E-Cdk2 complex diminishes the Cdk2 kinase activity in TSA-treated HeLa cells. On the other hand, p27 did not coelute with the larger Cdk2 complex, but eluted as a single major peak with a smaller apparent molecular mass than that of the p21-Cdk2 complex (Fig. 5) .
Up-regulation ofp2 1 Caused by Other Inhibitors ofHDAC
Since TSA is a specific inhibitor of HDAC,it is likely that other HDAC inhibitors causing histone hyperacetylation also induce p21 expression. This possibility was tested by using two structurally unrelated inhibitors of HDAC, trapoxin A, a fungal cyclic tetrapeptide compound which possesses a 2-amino-8-oxo-9,10-epoxydecanoyl (AOE) moiety3), and FR901228, a recently identified bacterial bicyclic depsipeptide with strong anticancer activity4) (Fig. 1) . These inhibitors strongly induce histone hyperacetylation in the cell. As expected, these two compounds also induced p21 expression in HeLa cells (Fig. 6) , suggesting that p21 induction is a general phenomenoncaused by histone hyperacetylation.
Effect ofTSA on Cell Proliferation ofp21-Deleted Human
Colorectal Carcinoma Cells
The above results suggest that the enhanced expression of p21 is responsible for TSA-induced cell cycle arrest in HeLa cells. However, it is difficult to prove conclusively its essential role in HeLa cells, since the p21-negative HeLa cells are yet unavailable. Instead, we tested whether a p21-null humancolorectal carcinoma cell line HCT116 (p21-/-) is resistant to TSAor not. As shown in Fig. 7 , the parental cell line HCT116 (p21+/+) was fairly sensitive to TSA compared with HeLa, but HCT116
(p21-/-) was found to be resistant to TSA. The IC50 was calculated to be 28ng/ml for HCT116 (p21-/-) and 4.4 ng/ml for HCT116 (p21+/+). However, the growth of HCT116 (p21-/-) cells was still inhibited by TSA in a concentration range similar to that for HeLa cells. These results suggest that p21 is important, but not the sole determinant for the TSA-induced growth inhibition in HCT116.
Discussion
In this study, we investigated the mechanism by which TSA causes a Gl cell cycle block in HeLa cells. First cyclin E-Cdk2 complexes were associated with p21 but not p27 (Fig. 5) . These results deny the possibility that p27 suppresses E-Cdk2 kinase activity in response to TSA, although previous reports showed that some negative growth signals can cause cell cycle arrest in Gl by increasing the association of p27 with a target CDK OCT. 2000 complex without modulating its level of expression14 It has been proposed that the repression of cyclin E expression in quiescent cells is mediated by pRb23). The cyclin E promoter contains E2F-binding sites, and this promoter activity can be inhibited by pRb in transient transfection assays. Recently, the E2F-pRb complex was shownto recruit HDAC to repress transcription and TSA released this repression by inhibiting HDAC7)8). Since HeLa cells lack the functional pRb due to inactivation by the E7 viral protein, some other mechanism is probably involved in TSA-induced up-regulation of cyclin E. It is also possible that the pRb function is not completely abrogated in HeLa cells. The cyclin A promoter also contains E2F-binding sites24), and pRb or related pocket proteins such as pi30 and 107 are involved in the repression of the cyclin A promoter. Therefore, the cyclin A promoter could be activated by the HDAC inhibitors as is the cyclin E promoter. In contrast to this prediction, however, our data clearly showed that cyclin A was down-regulated by inhibiting HDACin HeLa cells. The decrease in cyclin A expression in the butyrate-treated NIH3T3 cells was also In summary, we demonstrated that induction of p21 and inhibition of Cdk2 activity as a result of association of p21 with the cyclin E-Cdk2 complex play a critical role in TSAinduced growth inhibition in HeLa cells. Further experiments are needed to elucidate the mechanismsby which TSA induces specific induction of p21 and downregulation of cyclin A expression, which may be important for understanding how HDACinhibitors induce strong antitumor effects in vivo.
